株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸補助装置の世界市場:医療機器のパイプライン評価

Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020

発行 GlobalData 商品コード 361020
出版日 ページ情報 英文 85 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.92円で換算しております。
呼吸補助装置の世界市場:医療機器のパイプライン評価 Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020
出版日: 2020年02月15日 ページ情報: 英文 85 Pages
概要

当レポートでは、世界の呼吸補助具市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 呼吸補助装置の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:部門別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 呼吸補助装置の企業:治験段階別のパイプライン製品
  • 呼吸補助装置:治験段階別のパイプライン製品

第5章 呼吸補助装置市場:企業・製品の概要

  • ALung Technologies, Inc.
    • パイプライン製品および進行中の治験の概要
  • Breethe, Inc.
  • Case Western Reserve University
  • Haemair Limited
  • Liberate Medical, LLC
  • Lung Biotechnology PBC
  • McGowan Institute for Regenerative Medicine
  • MedArray Inc.
  • Merit Medical Systems, Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc.
  • Pneumedicare Ltd.
  • Rice University
  • The Charles Stark Draper Laboratory Inc
  • University of Arizona
  • University of California, Los Angeles
  • University of California, San Francisco
  • University of Kansas
  • University of Pittsburgh
  • Xenios AG

第6章 縫合糸市場:昨今の動向 (全20件)

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Table 2: Respiratory Assist Devices - Pipeline Products by Segment
  • Table 3: Respiratory Assist Devices - Pipeline Products by Territory
  • Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
  • Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Respiratory Assist Devices - Ongoing Clinical Trials
  • Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Table 9: Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Pulmonary Assist Device - Product Status
  • Table 11: Pulmonary Assist Device - Product Description
  • Table 12: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Hattler Catheter - Product Status
  • Table 14: Hattler Catheter - Product Description
  • Table 15: Hemolung RAS - Product Status
  • Table 16: Hemolung RAS - Product Description
  • Table 17: ULFED - <1L/min - Product Status
  • Table 18: ULFED - <1L/min - Product Description
  • Table 19: ULFED - 250 mL/min - Product Status
  • Table 20: ULFED - 250 mL/min - Product Description
  • Table 21: ALung Technologies Inc - Ongoing Clinical Trials Overview
  • Table 22: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
  • Table 23: Hemolung RAS - Enhanced Lung Protective Ventilation with Extracorporeal CO2 Removal During Acute Respiratory Distress Syndrome
  • Table 24: Hemolung RAS - Evaluation of Clinical Effectiveness of ECCO2R for the Treatment of Patients with Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  • Table 25: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
  • Table 26: Hemolung RAS - HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)
  • Table 27: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure
  • Table 28: Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Abylcap - Product Status
  • Table 30: Abylcap - Product Description
  • Table 31: Bellco Srl - Ongoing Clinical Trials Overview
  • Table 32: Abylcap - Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal with the Abylcap System
  • Table 33: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: OXY-1 - Product Status
  • Table 35: OXY-1 - Product Description
  • Table 36: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Portable Artificial Lung - Product Status
  • Table 38: Portable Artificial Lung - Product Description
  • Table 39: enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: RAS-Q - Product Status
  • Table 41: RAS-Q - Product Description
  • Table 42: Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: VentFree - Product Status
  • Table 44: VentFree - Product Description
  • Table 45: Liberate Medical LLC - Ongoing Clinical Trials Overview
  • Table 46: VentFree - Breath Synchronized Electrical Stimulation of the Abdominal Wall Muscles to Prevent Respiratory Muscle Atrophy During the Acute Stages of Mechanical Ventilation Therapy
  • Table 47: VentFree - VentFree: A Novel Abdominal Stimulator to Assist with Ventilator Weaning
  • Table 48: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Next Generation ECMO System - Product Status
  • Table 50: Next Generation ECMO System - Product Description
  • Table 51: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: 3D Bioprinted Lung Transplant - Product Status
  • Table 53: 3D Bioprinted Lung Transplant - Product Description
  • Table 54: Implantable Artificial Lung - Product Status
  • Table 55: Implantable Artificial Lung - Product Description
  • Table 56: MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: PALP - Product Status
  • Table 58: PALP - Product Description
  • Table 59: MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: BioLung - Product Status

List of Figures

  • Figure 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Figure 2: Respiratory Assist Devices - Pipeline Products by Segment
  • Figure 3: Respiratory Assist Devices - Pipeline Products by Territory
  • Figure 4: Respirator
目次
Product Code: GDME0907EPD

GlobalData's Medical Devices sector report, "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" provides an overview of Respiratory Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Respiratory Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Respiratory Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Respiratory Assist Devices Overview

3 Products under Development

  • 3.1 Respiratory Assist Devices - Pipeline Products by Stage of Development
  • 3.2 Respiratory Assist Devices - Pipeline Products by Segment
  • 3.3 Respiratory Assist Devices - Pipeline Products by Territory
  • 3.4 Respiratory Assist Devices - Pipeline Products by Regulatory Path
  • 3.5 Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Respiratory Assist Devices - Ongoing Clinical Trials

4 Respiratory Assist Devices - Pipeline Products under Development by Companies

  • 4.1 Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Respiratory Assist Devices - Pipeline Products by Stage of Development

5 Respiratory Assist Devices Companies and Product Overview

  • 5.1 Advanced Respiratory Technologies LLC Company Overview
    • 5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 ALung Technologies Inc Company Overview
    • 5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Bellco Srl Company Overview
    • 5.3.1 Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Breethe, Inc. Company Overview
    • 5.4.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Case Western Reserve University Company Overview
    • 5.5.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 enmodes GmbH Company Overview
    • 5.6.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Liberate Medical LLC Company Overview
    • 5.7.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 LivaNova PLC Company Overview
    • 5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Lung Biotechnology PBC Company Overview
    • 5.9.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 MAQUET Cardiopulmonary AG Company Overview
    • 5.10.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 MC3 Inc Company Overview
    • 5.11.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 McGowan Institute for Regenerative Medicine Company Overview
    • 5.12.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Miromatrix Medical Inc Company Overview
    • 5.13.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Pneumedicare Ltd. Company Overview
    • 5.14.1 Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Rice University Company Overview
    • 5.15.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 The Charles Stark Draper Laboratory Inc Company Overview
    • 5.16.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 U.S. Ann Arbor Healthcare System Company Overview
    • 5.17.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 University of Arizona Company Overview
    • 5.18.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 University of California Los Angeles Company Overview
    • 5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of Pittsburgh Company Overview
    • 5.20.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 X-COR Therapeutics Company Overview
    • 5.21.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6 Respiratory Assist Devices- Recent Developments

  • 6.1 Nov 13, 2019: Soleno Therapeutics provides corporate update and reports third quarter 2019 financial results
  • 6.2 Oct 31, 2019: Teleflex reports third quarter 2019 results
  • 6.3 Oct 08, 2019: CardioWise named a top-ten finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub
  • 6.4 Aug 07, 2019: Inogen announces second quarter 2019 financial results and updates 2019 guidance
  • 6.5 Aug 07, 2019: Soleno Therapeutics provides corporate update and reports second quarter 2019 financial results
  • 6.6 Aug 01, 2019: Teleflex reports second quarter 2019 results
  • 6.7 Jul 11, 2019: ALung announces the achievement of a key milestone in the U.S. based VENT-AVOID trial and continued progress towards completion of the trial
  • 6.8 May 21, 2019: Liberate Medical presents data from its pilot trial of VentFree, a muscle stimulator for mechanically ventilated patients, at the American Thoracic Society 2019 International Conference
  • 6.9 May 13, 2019: Soleno Therapeutics provides corporate update and reports first quarter 2019 financial results
  • 6.10 May 08, 2019: ALung announces that the independent Data and Safety Monitoring Board (DSMB) recommends continuation of VENT-AVOID trial and reports that significant progress continues with their clinical trial programs
  • 6.11 May 07, 2019: Inogen Announces First Quarter 2019 Financial Results and Updates 2019 Guidance
  • 6.12 May 02, 2019: Organ bioprinting gets a breath of fresh air
  • 6.13 May 02, 2019: Teleflex reports first quarter 2019 results
  • 6.14 Apr 29, 2019: Soleno Therapeutics names Gwen A. Melincoff to Board of Directors
  • 6.15 Mar 18, 2019: Soleno Therapeutics provides corporate update and reports fourth quarter and full-year 2018 financial results
  • 6.16 Feb 26, 2019: Inogen announces fourth quarter and full year 2018 financial results and updates 2019 guidance
  • 6.17 Feb 21, 2019: Teleflex reports fourth quarter and full year 2018 results; provides 2019 guidance

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer